Page last updated: 2024-09-05

sorafenib and Carcinoma, Islet Cell

sorafenib has been researched along with Carcinoma, Islet Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hobday, TJ; McWilliams, RR; Morris, JC; Robinson, SI; Sathananthan, A1

Other Studies

1 other study(ies) available for sorafenib and Carcinoma, Islet Cell

ArticleYear
Can sorafenib cause hypothyroidism?
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3

    Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Islet Cell; Female; Humans; Hypothyroidism; Liver Neoplasms; Niacinamide; Pancreatic Neoplasms; Phenylurea Compounds; Pyridines; Sorafenib

2007